Cargando…

Troglitazone Inhibits Matrix Metalloproteinase-9 Expression and Invasion of Breast Cancer Cell through a Peroxisome Proliferator-Activated Receptor γ-Dependent Mechanism

PURPOSE: Peroxisome proliferator-activated receptor γ (PPARγ) is involved in the pathology of numerous diseases including atherosclerosis, diabetes, obesity, and cancer. Matrix metalloproteinases (MMPs) play a significant role in tissue remodeling related to various processes such as morphogenesis,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, On-Yu, Youn, Hyun Jo, Jang, Hye-Yeon, Jung, Sung Hoo, Noh, Eun-Mi, Chae, Hee Suk, Jeong, Young-Ju, Kim, Won, Kim, Cheorl-Ho, Kim, Jong-Suk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Breast Cancer Society 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880963/ https://www.ncbi.nlm.nih.gov/pubmed/29628981 http://dx.doi.org/10.4048/jbc.2018.21.1.28

Ejemplares similares

Inhibition of cell invasion and migration by targeting matrix metalloproteinase-9 expression via sirtuin 6 silencing in human breast cancer cells
por: Hong, On-Yu, et al.
Publicado: (2022)

Protein tyrosine phosphatase controls breast cancer invasion through the expression of matrix metalloproteinase-9
por: Hwang, Bo-Mi, et al.
Publicado: (2013)

Troglitazone, a Ligand for Peroxisome Proliferator‐activated Receptor γ Inhibits Chemically‐induced Aberrant Crypt Foci in Rats
por: Kohno, Hiroyuki, et al.
Publicado: (2001)

Bruton's agammaglobulinemia tyrosine kinase (Btk) regulates TPA-induced breast cancer cell invasion via PLCγ2/PKCβ/NF-κB/AP-1-dependent matrix metalloproteinase-9 activation
por: Kim, Jeong-Mi, et al.
Publicado: (2021)

15d-PGJ(2) inhibits NF-κB and AP-1-mediated MMP-9 expression and invasion of breast cancer cell by means of a heme oxygenase-1-dependent mechanism
por: Jang, Hye-Yeon, et al.
Publicado: (2020)

Triptolide inhibits matrix metalloproteinase-9 expression and invasion of breast cancer cells through the inhibition of NF-κB and AP-1 signaling pathways
por: Hong, On-Yu, et al.
Publicado: (2021)

CDDO, a PPAR-γ ligand, inhibits TPA-induced cell migration and invasion through a PPAR-γ-independent mechanism
por: Jang, Hye-Yeon, et al.
Publicado: (2022)

Correlation of expression and activity of matrix metalloproteinase-9 and -2 in human gingival cells of periodontitis patients
por: Kim, Kyung-A, et al.
Publicado: (2013)

Troglitazone Induces Extracellular Matrix and Cytoskeleton Remodeling in Mouse Collecting Duct Cells
por: Corinaldi, Jaime, et al.
Publicado: (2012)

Increased Serum Activity of Matrix Metalloproteinase-9 in Patients with Acute Variceal Bleeding
por: Kwon, Oh Sang, et al.
Publicado: (2012)

Effect of troglitazone on radiation sensitivity in cervix cancer cells
por: An, Zhengzhe, et al.
Publicado: (2012)

Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, Restores Alveolar and Pulmonary Vascular Development in a Rat Model of Bronchopulmonary Dysplasia
por: Lee, Hyun Ju, et al.
Publicado: (2014)

Key Role of Microglial Matrix Metalloproteinases in Choroidal Neovascularization
por: Kim, Juhee, et al.
Publicado: (2021)

Crotonis Fructus Extract Inhibits 12-O-Tetradecanoylphorbol-13-Acetate-Induced Expression of Matrix Metalloproteinase-9 via the Activator Protein-1 Pathway in MCF-7 Cells
por: Song, Hyun-Kyung, et al.
Publicado: (2017)

Elevated matrix metalloproteinase-9 in patients with systemic sclerosis
por: Kim, Wan-Uk, et al.
Publicado: (2005)

Avenanthramide C Suppresses Matrix Metalloproteinase-9 Expression and Migration Through the MAPK/NF- κB Signaling Pathway in TNF-α-Activated HASMC Cells
por: Park, Junyoung, et al.
Publicado: (2021)

DHA blocks TPA-induced cell invasion by inhibiting MMP-9 expression via suppression of the PPAR-γ/NF-κB pathway in MCF-7 cells
por: Hwang, Jin-Ki, et al.
Publicado: (2017)

Troglitazone and Δ2Troglitazone Enhance Adiponectin Expression in Monocytes/Macrophages through the AMP-Activated Protein Kinase Pathway
por: Tsai, Jaw-Shiun, et al.
Publicado: (2014)

Downregulation of matriptase suppresses the PAR-2/PLCγ2/PKC-mediated invasion and migration abilities of MCF-7 breast cancer cells
por: Kim, Jeong-Mi, et al.
Publicado: (2021)

In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer
por: Fujita, Megumi, et al.
Publicado: (2017)

Associations of matrix metalloproteinase (MMP)-8, MMP-9, and their inhibitor, tissue inhibitor of metalloproteinase-1, with obesity-related biomarkers in apparently healthy adolescent boys
por: Shin, Youn Ho, et al.
Publicado: (2014)

Dihydroavenanthramide D prevents UV-irradiated generation of reactive oxygen species and expression of matrix metalloproteinase-1 and -3 in human dermal fibroblasts
por: Kim, Jeong-Mi, et al.
Publicado: (2013)

9-cis-Retinoic Acid and Troglitazone Impacts Cellular Adhesion, Proliferation, and Integrin Expression in K562 Cells
por: Hanson, Amanda M., et al.
Publicado: (2014)

Troglitazone suppresses telomerase activity independently of PPARγ in estrogen-receptor negative breast cancer cells
por: Rashid-Kolvear, Fariborz, et al.
Publicado: (2010)

Expression of the genes for peroxisome proliferator-activated receptor-γ, cyclooxygenase-2, and proinflammatory cytokines in granulosa cells from women with polycystic ovary syndrome
por: Lee, Joong Yeup, et al.
Publicado: (2017)

Troglitazone Attenuates TGF-β1-Induced EMT in Alveolar Epithelial Cells via a PPARγ-Independent Mechanism
por: Zhou, Beiyun, et al.
Publicado: (2012)

Retinoid X receptor and peroxisome proliferator-activated receptor-gamma agonists cooperate to inhibit matrix metalloproteinase gene expression
por: Burrage, Peter S, et al.
Publicado: (2008)

Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma.
por: Kim, T. S., et al.
Publicado: (1999)

Peroxisome Proliferator-Activated Receptor-γ in Thyroid Autoimmunity
por: Ferrari, Silvia Martina, et al.
Publicado: (2015)

Clinical Significance of Peroxisome Proliferator-Activated Receptor γ and TRAP220 in Patients with Operable Colorectal Cancer
por: Kwon, Kyung A, et al.
Publicado: (2016)

Protective Role of Matrix Metalloproteinase-9 in Ozone-Induced Airway Inflammation
por: Yoon, Hyoung-Kyu, et al.
Publicado: (2007)

Matrix Metalloproteinase 9 Point-of-Care Immunoassay Result Predicts Response to Topical Cyclosporine Treatment in Dry Eye Disease
por: Park, Jae Yong, et al.
Publicado: (2018)

Regulation of Matrix Remodeling by Peroxisome Proliferator-Activated Receptor-γ: A Novel Link Between Metabolism and Fibrogenesis
por: Wei, Jun, et al.
Publicado: (2012)

Troglitazone Enhances the Apoptotic Response of DLD-1 Colon Cancer Cells to Photodynamic Therapy
por: Park, Hyunju, et al.
Publicado: (2016)

Antiallergic Function of KR62980, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in a Mouse Allergic Rhinitis Model
por: Lee, Ji-Eun, et al.
Publicado: (2015)

PPARγ activation by troglitazone enhances human lung cancer cells to TRAIL-induced apoptosis via autophagy flux
por: Nazim, Uddin MD., et al.
Publicado: (2017)

Effects of Sulfonylureas on Peroxisome Proliferator-Activated Receptor γ Activity and on Glucose Uptake by Thiazolidinediones
por: Lee, Kyeong Won, et al.
Publicado: (2011)

Matrix Metalloproteinases and Glaucoma
por: Kim, Moo Hyun, et al.
Publicado: (2022)

Lack of the effect of lobeglitazone, a peroxisome proliferator-activated receptor-γ agonist, on the pharmacokinetics and pharmacodynamics of warfarin
por: Jung, Jin Ah, et al.
Publicado: (2015)

Role of Peroxisome Proliferator-Activated Receptor-γ in Vascular Inflammation
por: Ohshima, Kousei, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vcfn8k5l7cnruunt973krg509u